C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/1999
12/22/1999	CN1239096A Process for preparing camptothecine
12/21/1999	US6005096 For oligonucleotides that are modified to enhance the binding affinity and to bear detectable labels; for diagnostic use
12/16/1999	WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064394A1 Neuropeptide y5 receptor antagonists
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/15/1999	EP0963988A2 Method of making camptothecin and camptothecin analogs
12/15/1999	EP0963374A1 New furyl-pyridone compounds, useful as fungicides and obtained from the fungus cladobotryum
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	EP0792252B1 Monomers and composition which can be crosslinked and crosslinked polymers
12/15/1999	CN1238772A Novel phenanethridinium derivatives
12/15/1999	CN1047385C 3-indolylpiperidine and medinal composition containing them
12/14/1999	US6002000 Chemiluminescent compounds and methods of use
12/14/1999	US6001854 Pharmaceutical for treating of neurological and neuropsychiatric disorders
12/14/1999	US6001849 Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
12/14/1999	US6001846 Progesterone receptor modulators
12/14/1999	CA2136007C Novel compound with platelet aggregation inhibitor activity
12/09/1999	WO1999062908A2 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999	WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999	DE19824535A1 Neue Rhodamin-Derivate und deren Verwendung New rhodamine derivatives and their use
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2333770A1 Cell adhesion-inhibiting antinflammatory compounds
12/08/1999	EP0962497A1 Rhodamine derivates and their use in diagnostic systems
12/08/1999	CN1237974A Process for producing ecteinascidin compounds
12/07/1999	US5998614 Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process
12/07/1999	US5998461 Sleep disorders
12/07/1999	US5998460 Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof
12/07/1999	US5998459 Incotinence therapy
12/07/1999	US5998444 Antiasthma agents; neurokinin antagonist
12/07/1999	US5998433 Condensed compounds, their production and use
12/07/1999	US5998426 9,10 disubstituted camptothecin derivatives with antitumor activity
12/07/1999	US5998412 Sulfamide-metalloprotease inhibitors
12/07/1999	US5998410 Sulfonamide derivatives
12/01/1999	EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999	CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives
12/01/1999	CN1046943C Potycyclic antiparasitic agent, its process and composition containing same
11/1999
11/30/1999	US5994544 Producing a 5h-chromeno(3,4-f)quinoline
11/30/1999	US5994389 Insecticide
11/30/1999	US5994388 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
11/30/1999	US5994327 Opioid antagonist
11/30/1999	US5994274 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
11/25/1999	WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999	WO1999059594A1 Potassium channel agonists
11/25/1999	DE3943678C2 New isoquinoline:sulphonamide and naphthalene:sulphonamide cpds.
11/25/1999	CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999	CA2329916A1 Potassium channel agonists
11/24/1999	EP0959080A1 Initiators for radical polymerisation
11/24/1999	EP0958514A1 Novel photochromic heterocyclic fused indenonaphthopyrans
11/24/1999	EP0958345A2 Activators for per compounds
11/24/1999	EP0958285A1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES
11/24/1999	CN1236362A Azinyloxy- and phenoxy-diaryl-carboxylic derivatives, their preparation and use as mixed ET/ET encothelin receptor
11/24/1999	CN1236012A Polycyclic antiparasitic agents, process and strain for their preparation and their use
11/24/1999	CN1235968A Substituted tricyclics
11/24/1999	CN1235967A Carbazolone derivatives
11/24/1999	CN1046727C HIV protease inhibitors
11/24/1999	CN1046723C Tetracyclic compounds, pharmaceutical containing them and its use
11/23/1999	US5990316 Substituted (1,4)dioxino(2,3-F) 6,7-Dichloro-6,7-difluoro-2-trichloromethyl-[1,4]-dioxino-[2,3-f]-benzim idazole and their use in pest control
11/23/1999	US5990132 Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
11/23/1999	US5990123 For treating migraine and cephalic pain, and conditions related to vasodilation; pharmacuetical compositions and methods of synthesis via reductive n-alkylation
11/23/1999	US5990120 Given structure, where a five-membered aza-heterocycle is fused to ring (a) of camptothecin at positions 9 and 10; compounds possess high antitumor activity by inhibition of topoisomerase; methods for their synthesis
11/21/1999	CA2238162A1 Tricyclic spiro compounds as 5ht1d receptor antagonists
11/18/1999	WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999	WO1999058518A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999	WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058125A1 Metabolites of ecteinascidin 743
11/18/1999	CA2330557A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999	CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999	EP0957109A2 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
11/17/1999	EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999	EP0819135B1 Sugar-modified cytostatics
11/17/1999	CN1046520C Bicyclic oxazine and thiazine oxazolidinone
11/17/1999	CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/16/1999	US5986114 Benzopyranol derivatives
11/16/1999	US5985903 Microbicidal benzotriazoles
11/16/1999	US5985888 Camptothecin compounds with combined topoisomarase I inhibition and DNA alkylation properties
11/16/1999	US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999	US5985869 Benzoheterocyclic compounds
11/16/1999	US5985867 Treating hiv infection
11/16/1999	CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/16/1999	CA2048896C Fluoroethylcamptothecin derivatives
11/11/1999	WO1999057118A1 Novel n-oxides
11/11/1999	WO1999057117A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
11/11/1999	WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999	DE19838506A1 Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen The indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferations
11/11/1999	CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999	CA2330738A1 Novel n-oxides of benzonaphthyridines
11/10/1999	EP0954526A2 Serine protease inhibitors
11/10/1999	EP0954522A1 Novel substituted naphthopyrans
11/10/1999	EP0547165B1 Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
11/10/1999	CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999	CN1046283C Process for preparation of 9-amino camptothecin
11/10/1999	CN1046282C Photockromic heterocyclobenzopyrane and preparing method and use thereof
11/10/1999	CN1046280C Noval thiophenesulfonylurea derivatives and herbidical composition containing same
11/10/1999	CN1046271C Substituted pyrimidines and fungicidal and pesticidal and anti-septic composition containing same
11/09/1999	US5981576 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
11/09/1999	US5981567 Substituted spiroheterocyclic 1h-3-aryl-pyrrolidine-2,4-dione derivatives and their use as pesticides
11/09/1999	US5981542 Topoisomerase inhibitors; antitumoral drugs

1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 298